The KidneyX Artificial Kidney Prize is a competition to accelerate the development of artificial kidneys toward human clinical trials. In Phase 1, the Artificial Kidney Prize calls for demonstrated scientific and technical proofs of concept with detailed development plans for solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. For this competition, artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived.The deadline for Phase 1 submissions is 4:59 p.m. ET on March 24, 2021.
Please submit at least one hour before the deadline to ensure your completed submission is received. This form is best viewed using Chrome, Firefox, or Internet Explorer 10 or higher. To prevent the loss of any entered information, please save the form as a draft prior to attaching any files or editing your team contact information. When submitting, please do not reload the form or exit the browser until you see a message confirming we have received your submission. If you encounter any issues, please email [email protected]
with a description of the problem, a screenshot, and the date and time of the occurrence.Please upload a document addressing the following content areas:Approach summary:
An overview of the proof of concept and development plan, including the problem(s) the solution is solving and how it advances the state of innovation for artificial kidneys.Solution description:
A description of the kidney function(s) the enabling solution could advance or support in artificial kidneys. This should also include rationale for maturity, safety, and effectiveness claims, such as data from testing (bench or beyond) or other proof of concept evidence. Each submission must include at least one clear visual (preferably a video file) of the actual proof of concept that demonstrates functionality. Please ensure the visual or video hyperlink is clearly labeled in your submission documentation; entrants are responsible for ensuring linked content is accessible during the evaluation period. Patient perspective:
A summary of patient input in the development process, and a description of how it impacts and improves both patient quality of life and clinical outcomes.Research and development:
A summary of past progress, current development status (including existing intellectual property), and a detailed development plan for continued iteration, testing, and safety evaluation in Phase 2 of the competition, and/or beyond.Artificial kidney integration:
A description of potential partnerships or plans for future collaborative efforts. This should include an approach for integration with other solutions, or further development of integrated solutions, in the next 3-4 years. It should also include a strategy to address potential intellectual property (IP) issues.Program management:
A description of past funding and how it has been used to advance development to date. This section should also include a forward-looking budget, timeline, and roadmap to achieve future regulatory approvals and manufacturing at scale.Team description:
A description of the team, including areas of expertise, as well as experience/success developing analogous solutions.